USPTO Examiner BOCKELMAN MARK - Art Unit 3792

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19055432ANATOMICAL MANIPULATION DEVICEFebruary 2025January 2026Allow1120YesNo
18822854APPARATUS AND METHOD FOR MANIPULATING THE NERVOUS SYSTEM BY ELECTRIC FIELDSSeptember 2024October 2025Allow1321NoNo
18615896INTRAVASCULAR BLOOD PUMPS AND METHODS OF USE AND MANUFACTUREMarch 2024March 2025Allow1210NoNo
18615517SYSTEM AND METHOD FOR TRANSMITTING RADIO FREQUENCY ENERGY AT A VIRUS RESONANT FREQUENCY TO DISABLE ITMarch 2024April 2025Allow1310YesNo
18688595Electrostatic Therapeutic DeviceMarch 2024June 2025Allow1600NoNo
18441814ELECTRODE ASSEMBLYFebruary 2024September 2025Allow1911NoNo
18435322TREATMENT DEVICEFebruary 2024December 2024Allow1010NoNo
18422099FLUID SEALS FOR CATHETER PUMP MOTOR ASSEMBLYJanuary 2024February 2025Allow1310NoNo
18410217IMPLANTABLE POWER ADAPTERJanuary 2024July 2025Allow1810NoNo
18393268STIMULATION WITH ELECTRODE ARRAYSDecember 2023January 2025Allow1310NoNo
18540437MINIMALLY INVASIVE LEADLESS NEUROSTIMULATION DEVICEDecember 2023January 2025Allow1310NoNo
18528358METHOD OF USING PHOTON MODULATION FOR REGULATION OF HORMONES IN MAMMALSDecember 2023February 2025Allow1510NoNo
18514470PARTIAL NERVE CONDUCTION BLOCK USING A SEPARATED INTERFACE NERVE ELECTRODE (SINE)November 2023September 2025Allow2211NoNo
18388191METHODS AND SYSTEMS OF IMPROVING AND MONITORING ADDICTION USING CUE REACTIVITYNovember 2023January 2026Allow2650NoNo
18559377NEURAL IMPLANT BASED ON A CELLULOSE THIN FILM AND CORRESPONDING FABRICATION PROCESSNovember 2023October 2025Allow2300NoNo
18379221BLOOD PUMPOctober 2023December 2024Allow1510NoNo
18485667DEVICE FOR ENHANCING MANDIBULAR BONE GROWTHOctober 2023December 2023Allow200YesNo
18551765SYSTEMS AND METHODS FOR IMPLANTABLE ELECTRODES WITH FEEDBACK FOR APPLICATION OF ELECTRIC FIELD THERAPY WITHIN THE BODYSeptember 2023December 2024Allow1520YesNo
18229466INTERNAL ULTRAVIOLET THERAPYAugust 2023April 2025Allow2020YesNo
18228748ELECTRODE CONNECTION AND METHOD THEREFORAugust 2023August 2024Allow1210NoNo
18355382ELECTRODE SYSTEM FOR ELECTRICAL STIMULATIONJuly 2023June 2025Allow2211YesNo
18347073BIOELECTRIC OPG TREATMENT OF CANCERJuly 2023March 2026Abandon3210NoNo
18216925Cardiac Pump With Speed Adapted for Ventricle UnloadingJune 2023March 2025Allow2020NoNo
18215603ELECTRICAL STIMULATION DEVICES FOR CANCER TREATMENTJune 2023January 2025Allow1911NoNo
18038708ELECTRIC FIELD CANCER TREATMENT APPARATUS AND METHOD USING ROTATING ALTERNATING CURRENT ELECTRIC FIELDMay 2023January 2024Allow810NoNo
18037124BIOSIGNAL ANALYSIS SYSTEMMay 2023September 2025Allow2800NoNo
18195690SENSING REFERENCE ELECTRODE FOR PERCUTANEOUS NEUROMODULATION TRIALSMay 2023September 2024Allow1710NoNo
18144351BIOCOMPATIBLE SOFT PRESSURE SENSOR AND METHOD OF MONITORING PRESSURE SUBCUTANEOUSLYMay 2023September 2025Allow2800NoNo
18137614SYSTEM AND METHOD FOR IMPLANTABLE NEURAL SENSING AND STIMULATING PROBESApril 2023March 2026Allow3411YesNo
18137769AV SYNCHRONOUS SEPTAL PACINGApril 2023March 2025Allow2311YesNo
18194896ELECTRICALLY ANESTHETIZING A PERIPHERAL NERVE WITH ON-DEMAND ELECTRICAL NERVE BLOCK FOR CHRONIC PAIN MANAGEMENTApril 2023November 2024Allow1910YesNo
18023828SYSTEMS AND DEVICES FOR TREATING LUNG TUMORSFebruary 2023October 2025Allow3200NoNo
18175424ENDOVASCULAR LEAD DESIGN AND DELIVERY SYSTEMSFebruary 2023February 2026Allow3511NoNo
18171613Stimulation Configuration Variation to Control Evoked Temporal PatternsFebruary 2023March 2025Allow2520NoNo
18021257Method for Focused Transcranial Electrical Current StimulationFebruary 2023August 2025Allow3010NoNo
18041657ELECTROPORATION SHIELD FOR IMPLANTABLE ELECTRODESFebruary 2023February 2026Allow3610NoNo
18105069High Voltage, High Efficiency Sine Wave Generator that Prevents Spikes During Amplitude Adjustments and Switching of ChannelsFebruary 2023July 2024Allow1710NoNo
18104570METHOD FOR NEUROMODULATION TREATMENT OF LOW URINARY TRACT DYSFUNCTIONFebruary 2023September 2023Allow810NoNo
18103652TREATMENT OF CONGESTIVE HEART FAILURE WITH ELECTRICAL STIMULATION, AND ASSOCIATED SYSTEMS AND METHODSJanuary 2023September 2024Abandon1910NoNo
18069606ENERGY CONSUMPTION REDUCTION FOR MEDICAL DEVICE CONNECTIVITYDecember 2022June 2025Allow3000NoNo
18079361DEVICES, SYSTEMS, AND METHODS FOR DIAGNOSIS AND TREATMENT OF OVERACTIVE BLADDERDecember 2022February 2026Allow3810NoNo
17928736RADIO FREQUENCY MICRONEEDLE ARRAY CONTROL DEVICE, METHOD AND RADIO FREQUENCY MICRONEEDLE THERAPEUTIC APPARATUSNovember 2022October 2025Allow3410NoNo
17924363INTEGRATED ARTIFICIAL PANCREAS WITH MULTIPLE INFUSION MODESNovember 2022July 2025Allow3210NoNo
17923606DIABETIC COMPLICATION MONITORING DEVICE AND DIABETIC COMPLICATION MANAGEMENT SYSTEM USING SAMENovember 2022July 2025Allow3210NoNo
17959540PHYSIOLOGICAL PARAMETER SENSOR HELMETOctober 2022June 2024Allow2130YesNo
17916564METHOD AND APPARATUS FOR CORRECTING ELECTROCARDIOGRAM READINGSeptember 2022October 2025Allow3710NoNo
17930994SUBSTERNAL LEADLESS ELECTRICAL STIMULATION SYSTEMSeptember 2022July 2025Abandon3420YesNo
17910209ENHANCING AUDITORY PERCEPTS WITH VESTIBULAR SIMULATIONSeptember 2022August 2025Allow3511NoNo
17894889WEARABLE SYSTEM FOR THE EARAugust 2022November 2025Abandon3910NoNo
17887160DETECTION OF ATRIAL FIBRILLATIONAugust 2022March 2025Allow3130NoNo
17884903MOTOR CABLES FOR INTRAVASCULAR BLOOD PUMPSAugust 2022May 2025Allow3311NoNo
17759731Selective Stimulation of Peripheral NervesJuly 2022September 2025Allow3811NoNo
17875310Implant Including NanogeneratorJuly 2022April 2025Allow3211YesNo
17869091SYSTEMS AND METHODS OF INTEGRATING AMBULATORY MEDICAL DEVICESJuly 2022April 2024Allow2110NoNo
17792454SYSTEM FOR PREDICTING ADVERSE EVENT IN PATIENTJuly 2022March 2025Abandon3210NoNo
17862055Systems And Methods Of Detecting And Treating Obstructive Sleep ApneaJuly 2022March 2026Allow4440YesNo
17811871SEMICONDUCTOR ACUPUNCTURE DEVICE AND METHOD OF USEJuly 2022February 2025Allow3120YesNo
17840994METHOD OF PERCUTANEOUSLY IMPLANTING A MEDICAL IMPLANT AND A DELIVERY DEVICE FOR PERCUTANEOUS DELIVERY OF A MEDICAL IMPLANTJune 2022March 2025Allow3311NoNo
17784278IMPLANTABLE GUIDE ELEMENT AND METHODS OF FABRICATION AND USE THEREOFJune 2022October 2025Abandon4010NoNo
17783497DEVICE FOR CLASSIFYING CONDITION OF SUBJECT AND NON-TRANSITORY COMPUTER-READABLE MEDIUM HAVING RECORDED COMPUTER PROGRAM FOR THE DEVICEJune 2022December 2024Allow3110YesNo
17782694PROVIDING FEEDBACK ON A TREATMENT OPERATION PERFORMED ON A BODY PART OF A SUBJECTJune 2022September 2025Abandon4010NoNo
17782304RUNTIME OPTIMISED ARTIFICIAL VISIONJune 2022August 2025Abandon3910NoNo
17743436CARDIAC EVENT SENSING IN AN IMPLANTABLE MEDICAL DEVICEMay 2022October 2024Allow2910NoNo
17738544DISTRIBUTED DEVICE CONTROL AND WEARABLE SYSTEM FOR VAGUS NERVE STIMULATIONMay 2022February 2026Allow4621NoNo
17736432CARTILAGE TREATMENTMay 2022March 2026Allow4620NoNo
17661150SUBSTERNAL ELECTRICAL STIMULATION SYSTEMApril 2022January 2026Allow4540YesNo
17731801VESTIBULAR NERVE STIMULATIONApril 2022June 2024Allow2611NoNo
17661103IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (ICD) SYSTEM INCLUDING SUBSTERNAL LEADApril 2022July 2025Allow3930YesNo
17661078PULSE APPLICATION METHOD AND PULSE APPLICATION DEVICEApril 2022April 2025Abandon3510NoNo
17724821METHOD FOR NEUROMODULATION TREATMENT OF NEURODEGENERATIVE DISEASEApril 2022January 2023Allow910NoNo
17659966Stimulation Modes to Adapt Customized Stimulation Parameters for Use in a Spinal Cord Stimulation SystemApril 2022February 2024Allow2210NoNo
17657820ELECTROCARDIOGRAM DEVICE AND DOCKING STATIONSApril 2022August 2025Allow4030YesNo
17707674COLLECTION OF CLINICAL DATA FOR GRAPHICAL REPRESENTATION AND ANALYSISMarch 2022February 2024Allow2210NoNo
17691694CONFIGURABLE COMPARATOR ECG STORAGE AND DISPLAY IN A WEARABLE DEFIBRILLATOR SYSTEMMarch 2022June 2025Allow4020NoNo
17651735SYSTEMS AND METHODS FOR DETECTING MENTAL FATIGUE BY A USER OF AN IHS (INFORMATION HANDLING SYSTEM)February 2022February 2025Allow3610NoNo
17650459COMPRESSIBLE, MINIMALLY INVASIVE IMPLANTS AND RELATED SYSTEMS AND METHODSFebruary 2022October 2025Allow4411YesNo
17565327SURGICAL SYSTEM AND PROCEDURE FOR TREATMENT OF THE TRABECULAR MESHWORK AND SCHLEMM'S CANAL USING A FEMTOSECOND LASERDecember 2021February 2024Allow2630YesNo
17561437NEUROMODULATION MEDICAL TREATMENT DEVICEDecember 2021August 2023Allow1921NoNo
17644765APPARATUS AND METHODS FOR MAINTAINING PHYSIOLOGICAL FUNCTIONSDecember 2021December 2024Allow3620NoNo
17552311INTRAVASCULAR BLOOD PUMPS AND METHODS OF USE AND MANUFACTUREDecember 2021December 2023Allow2410NoNo
17643851ABLATION SYSTEMS AND METHODS FOR TREATING PRESBYOPIADecember 2021March 2025Allow3930YesNo
17545739IMPLANTABLE ELECTRODE DEVICE AND METHOD OF FORMING AN IMPLANTABLE ELECTRODE DEVICEDecember 2021January 2025Allow3711NoNo
17596340Spinal Cord Stimulation System Determining Optimal Sub-Perception Therapy by Using Neural DoseDecember 2021June 2025Allow4211NoNo
17542940BLOOD PUMPDecember 2021July 2023Allow1900NoNo
17541554COMPUTER-ASSISTED TELE-OPERATED SURGERY SYSTEMS AND METHODSDecember 2021August 2024Allow3220NoNo
17539235METHOD AND SYSTEM FOR VALIDATING SAFETY OF A MEDICAL DEVICE WHEN EXPOSED TO MAGNETIC RESONANCE IMAGING FIELDSDecember 2021February 2024Allow2610YesNo
17613869SYSTEMS AND METHODS FOR TREATING INCONTINENCENovember 2021March 2025Allow3920NoNo
17455585DEVICES, SYSTEMS, AND METHODS FOR TREATING AND PREVENTING DISEASENovember 2021August 2025Allow4521YesNo
17527341ELECTRODE CONNECTION AND METHOD THEREFORNovember 2021July 2023Allow2000NoNo
17595169METHODS TO REDUCE FLASHES ON ELECTRODESNovember 2021January 2025Allow3811NoNo
17609756A TISSUE STIMULATION DEVICE WITH DISTAL AND PROXIMAL RETURN ELECTRODENovember 2021April 2025Allow4220YesNo
17453611LOW HEALTHCARE PROVIDER INTERACTION AND OUTCOME BASED PROGRAMMINGNovember 2021December 2024Allow3701NoNo
17607062FLEXIBLE ELECTRODE MADE OF A METAL BASE MATERIALOctober 2021June 2024Allow3200NoNo
17510019ELASTIC NEURAL ELECTRODE AND METHOD FOR FABRICATING THE SAMEOctober 2021January 2022Allow300NoNo
17451255ELECTROCARDIOGRAM PROCESSING SYSTEM FOR DELINEATION AND CLASSIFICATIONOctober 2021April 2022Allow620YesNo
15734523SYSTEMS AND METHODS FOR DETERMINING A FLOW SPEED OF A FLUID FLOWING THROUGH A CARDIAC ASSIST DEVICEOctober 2021January 2025Allow5011NoNo
17498610MODULAR TREATMENT DEVICEOctober 2021September 2023Allow2300NoNo
17600649DEVICE FOR ACTING ON AT LEAST PARTS OF A BODYOctober 2021July 2025Allow4520NoNo
17492130Method and Apparatus for Accurate Placement of Electrocardiogram ElectrodesOctober 2021February 2025Allow4130YesNo
17485292MINIMALLY INVASIVE LEADLESS NEUROSTIMULATION DEVICESeptember 2021June 2023Allow2100NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner BOCKELMAN, MARK.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
2
Examiner Affirmed
0
(0.0%)
Examiner Reversed
2
(100.0%)
Reversal Percentile
99.7%
Higher than average

What This Means

With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
16
Allowed After Appeal Filing
8
(50.0%)
Not Allowed After Appeal Filing
8
(50.0%)
Filing Benefit Percentile
84.2%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 50.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner BOCKELMAN, MARK - Prosecution Strategy Guide

Executive Summary

Examiner BOCKELMAN, MARK works in Art Unit 3792 and has examined 477 patent applications in our dataset. With an allowance rate of 87.2%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 31 months.

Allowance Patterns

Examiner BOCKELMAN, MARK's allowance rate of 87.2% places them in the 66% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by BOCKELMAN, MARK receive 1.61 office actions before reaching final disposition. This places the examiner in the 31% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by BOCKELMAN, MARK is 31 months. This places the examiner in the 58% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +8.4% benefit to allowance rate for applications examined by BOCKELMAN, MARK. This interview benefit is in the 39% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 35.6% of applications are subsequently allowed. This success rate is in the 80% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 45.1% of cases where such amendments are filed. This entry rate is in the 69% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 75.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 61% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 87.5% of appeals filed. This is in the 81% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 36.6% are granted (fully or in part). This grant rate is in the 25% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 3.6% of allowed cases (in the 81% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 3.8% of allowed cases (in the 77% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • RCEs are effective: This examiner has a high allowance rate after RCE compared to others. If you receive a final rejection and have substantive amendments or arguments, an RCE is likely to be successful.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.